XORTX Therapeutics Inc (XRTX)
3.22
-0.14
(-4.17%)
USD |
NASDAQ |
Apr 15, 16:00
3.24
+0.02
(+0.62%)
After-Hours: 20:00
XORTX Therapeutics Total Assets (Quarterly): 6.640M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 6.640M |
| June 30, 2023 | 7.801M |
| March 31, 2023 | 9.659M |
| December 31, 2022 | 12.34M |
| September 30, 2022 | 10.94M |
| June 30, 2022 | 12.45M |
| March 31, 2022 | 14.77M |
| December 31, 2021 | 17.28M |
| September 30, 2021 | 6.141M |
| June 30, 2021 | 5.914M |
| March 31, 2021 | 6.534M |
| December 31, 2020 | 1.796M |
| September 30, 2020 | 1.991M |
| June 30, 2020 | 2.105M |
| March 31, 2020 | 2.368M |
| December 31, 2019 | 0.8329M |
| September 30, 2019 | 0.8129M |
| June 30, 2019 | 0.828M |
| March 31, 2019 | 0.8449M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.9289M |
| September 30, 2018 | 1.050M |
| June 30, 2018 | 1.199M |
| March 31, 2018 | 1.409M |
| December 31, 2017 | 0.3901M |
| November 30, 2017 | 0.039M |
| September 30, 2017 | 0.3422M |
| August 31, 2017 | 0.0547M |
| May 31, 2017 | 0.103M |
| February 28, 2017 | 0.1446M |
| November 30, 2016 | 0.3399M |
| August 31, 2016 | 0.182M |
| May 31, 2016 | 0.1873M |
| February 29, 2016 | 0.2034M |
| November 30, 2015 | 0.2364M |
| August 31, 2015 | 0.1445M |
| May 31, 2015 | 0.1544M |
| February 28, 2015 | 0.1439M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.8129M
Minimum
Sep 2019
17.28M
Maximum
Dec 2021
6.734M
Average
6.337M
Median
Total Assets (Quarterly) Benchmarks
| ImmunoPrecise Antibodies Ltd | 54.67M |
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.5538M |
| Shareholders Equity (Quarterly) | 6.086M |